Mangrove Partners’s Drugs Made In America Acquisition Corp. Ordinary Shares DMAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.57M Hold
350,000
0.38% 44
2025
Q1
$3.51M Buy
+350,000
New +$3.51M 0.38% 47